212 related articles for article (PubMed ID: 4361781)
1. Reduced acetylcholine receptors in myasthenia gravis.
Drachman DB; Fambrough DM; Satyamurti S
Trans Am Neurol Assoc; 1973; 98():93-5. PubMed ID: 4361781
[No Abstract] [Full Text] [Related]
2. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
Punga AR; Flink R; Askmark H; Stålberg EV
Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
[TBL] [Abstract][Full Text] [Related]
3. Effects on neuromuscular function of acute chronic exposure to cholinesterase inhibitors in man and in the rat.
Roberts DV; Taylor K; Wilson A
J Physiol; 1971 Dec; 219(2):15P. PubMed ID: 4333825
[No Abstract] [Full Text] [Related]
4. The pharmacological basis for the treatment of myasthenia gravis.
Flacke W
Pharmacol Physicians; 1970 Jun; 4(6):1-7. PubMed ID: 4316342
[No Abstract] [Full Text] [Related]
5. Potentiation of muscle relaxants by quinidine.
Miller RD; Way WL; Katzung BG
Anesthesiology; 1968; 29(5):1069-70. PubMed ID: 4299762
[No Abstract] [Full Text] [Related]
6. Myasthenia gravis and myasthenic syndrome: simulation of twitch strength with or without therapy.
Nigrovic V; Amann A; Bhatt S
Muscle Nerve; 2005 Dec; 32(6):745-50. PubMed ID: 16094654
[TBL] [Abstract][Full Text] [Related]
7. Subacute denervation: a means of disclosing mammalian motor nerve terminals as critical sites of acetylcholine and facilitatory drug actions.
Okamoto M; Riker WF
J Pharmacol Exp Ther; 1969 Apr; 166(2):217-24. PubMed ID: 4304912
[No Abstract] [Full Text] [Related]
8. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
9. [The Grob test in myasthenia: discussion of an atypical case].
Gambi D; Tonali P
Riv Neurol; 1971; 41(3):161-9. PubMed ID: 4331238
[No Abstract] [Full Text] [Related]
10. Acetylcholinesterase inhibitors in MG: to be or not to be?
Punga AR; Stålberg E
Muscle Nerve; 2009 Jun; 39(6):724-8. PubMed ID: 19260048
[TBL] [Abstract][Full Text] [Related]
11. Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction.
Bender AN; Ringel SP; Engel WK; Daniels MP; Vogel Z
Lancet; 1975 Mar; 1(7907):607-9. PubMed ID: 47950
[No Abstract] [Full Text] [Related]
12. [Mechanisms of compensatory reinnervation in axon injuries of peripheral nerves (review)].
Gekht BM; Nikitin SS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):294-300. PubMed ID: 3518317
[No Abstract] [Full Text] [Related]
13. [The surgical treatment of myasthenia].
Le Brigand H; Noviant Y
Thoraxchir Vask Chir; 1970 Apr; 18(2):169-80. PubMed ID: 4316749
[No Abstract] [Full Text] [Related]
14. Pharmacology of myasthenia gravis.
Dipalma JR
Am Fam Physician; 1980 Oct; 22(4):158-9. PubMed ID: 7424763
[No Abstract] [Full Text] [Related]
15. Clinical and physiological studies of the effect of guanidine of patients with myasthenia gravis.
Brown JC; Johns RJ
Johns Hopkins Med J; 1969 Jan; 124(1):1-8. PubMed ID: 5762895
[No Abstract] [Full Text] [Related]
16. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
17. The acetylcholine receptor in normal and pathologic states. Immunoperoxidase visualization of alpha-bungarotoxin binding at a light and electron-microscopic level.
Bender AN; Ringel SP; Engel WK
Neurology; 1976 May; 26(5):477-83. PubMed ID: 177905
[TBL] [Abstract][Full Text] [Related]
18. [Electron microscopic study of the neuromuscular junction in myasthenia gravis].
Santa T; Kuroiwa Y
No To Shinkei; 1970 Jun; 22(6):649-55. PubMed ID: 5468804
[No Abstract] [Full Text] [Related]
19. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
Molenaar PC; Oen BS; Plomp JJ; Van Kempen GT; Jennekens FG; Hesselmans LF
Eur J Pharmacol; 1991 Apr; 196(1):93-101. PubMed ID: 1874282
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of action of muscle relaxants and its clinical problems].
Suzuki H
Masui; 1974 Aug; 23(8):679-92. PubMed ID: 4372420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
